SION - Sionna Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$27.20
DETAILS
HIGH:
$60.00
LOW:
$5.00
MEDIAN:
$7.00
CONSENSUS:
$27.20
UPSIDE:
414.18%
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0.2 | 0.2 | 0 | 0.1 | 0 | 0 | 0 | 0.2 | 0 | 0 |
| Gross Profit | 0 | (0.2) | (0.2) | 0 | (0.1) | 0 | 0 | 0 | (0.2) | 0 | 0 |
| Operating Expenses | |||||||||||
| R&D Expenses | 21.9 | 19.0 | 15.2 | 16.0 | 15.4 | 13.7 | 14.3 | 24.6 | 8.2 | 10.2 | 9.9 |
| SG&A Expenses | 10.6 | 10.5 | 9.9 | 7.2 | 6.5 | 5.6 | 3.9 | 4.2 | 2.9 | 2.6 | 2.7 |
| Other Expenses | 0 | 0 | (1.6) | 0.5 | (0.1) | 0.4 | 0 | (0.8) | 0 | 0.4 | 0 |
| Operating Expenses | 32.5 | 29.4 | 23.5 | 23.8 | 21.8 | 19.7 | 18.1 | 28.0 | 11.1 | 13.1 | 12.6 |
| Operating Income | |||||||||||
| Operating Income | (32.5) | (29.6) | (23.6) | (23.8) | (21.9) | (19.7) | (18.1) | (28.0) | (11.3) | (13.1) | (12.6) |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 2.6 | 2.8 | 3.2 | 3.5 | 3.7 | 3 | 2.1 | 2.4 | 2.6 | 1.1 | 0.6 |
| Profitability | |||||||||||
| EBITDA | (29.9) | (26.6) | (16.8) | (19.8) | (17.9) | (16.1) | (15.7) | (25.3) | (8.4) | (11.5) | (11.7) |
| EBIT | (29.9) | (26.8) | (17.3) | (20.3) | (18.1) | (16.5) | (15.8) | (25.4) | (8.6) | (11.8) | (11.9) |
| Income Before Tax | (29.9) | (26.8) | (20.4) | (20.3) | (18.1) | (16.5) | (15.8) | (25.4) | (8.6) | (11.8) | (11.9) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (29.9) | (26.8) | (20.4) | (20.3) | (18.1) | (16.5) | (15.8) | (25.4) | (8.6) | (11.8) | (11.9) |
| Per Share Data | |||||||||||
| EPS (Basic) | -0.66 | -0.60 | -0.46 | -0.46 | -0.41 | -0.37 | -0.36 | -0.58 | -0.19 | -0.27 | -0.27 |
| EPS (Diluted) | -0.66 | -0.60 | -0.46 | -0.46 | -0.41 | -0.37 | -0.36 | -0.58 | -0.19 | -0.27 | -0.27 |
| Shares Outstanding | 45.1 | 44.9 | 40.0 | 44.5 | 44.1 | 44.1 | 44.1 | 44.1 | 44.1 | 44.1 | 44.1 |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash & Cash Equivalents | 63.3 | 63.3 | 58.5 | 50.8 | 41.0 | 82.7 | 37.8 | 35.7 | 38.5 |
| Short-Term Investments | 147.7 | 152.8 | 177.4 | 197.5 | 221.6 | 187.0 | 109.8 | 101.7 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 5.1 | 4.8 | 5.5 | 4.0 | 4.2 | 4.0 | 3.5 | 2.9 | 0.7 |
| Total Current Assets | 216.1 | 221.0 | 241.4 | 252.3 | 266.7 | 273.7 | 151.0 | 140.3 | 39.2 |
| Non-Current Assets | |||||||||
| Property, Plant & Equipment | 8.3 | 8.8 | 9.2 | 9.3 | 9.6 | 10.0 | 10.3 | 10.6 | 11.7 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 57.2 | 73.8 | 74.4 | 76.7 | 74.7 | 85.0 | 20.5 | 43.4 | 1.0 |
| Other Non-Current Assets | 1.6 | 1.5 | 1.0 | 1.0 | 1.0 | 1.0 | 4.0 | 2.9 | 0.0 |
| Total Non-Current Assets | 67.1 | 84.1 | 84.5 | 86.9 | 85.3 | 96.0 | 34.8 | 56.9 | 12.7 |
| Total Assets | 283.2 | 305.0 | 326.0 | 339.3 | 352.0 | 369.7 | 185.8 | 197.3 | 51.9 |
| Current Liabilities | |||||||||
| Account Payables | 0.5 | 2.1 | 0.8 | 1.5 | 0.9 | 5.0 | 1.2 | 0.1 | 0.7 |
| Short-Term Debt | 0 | 0 | 0 | 1.2 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 8.9 | 1.5 | 4.7 | 4.1 | 3.5 | 1.0 | 3.0 | 2.0 | 3.1 |
| Total Current Liabilities | 10.8 | 9.8 | 11.7 | 9.9 | 7.5 | 9.5 | 10.4 | 6.5 | 8.0 |
| Non-Current Liabilities | |||||||||
| Long-Term Debt | 0 | 7.1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 330.4 | 330.4 | 149.0 |
| Total Non-Current Liabilities | 6.7 | 7.1 | 7.4 | 7.8 | 8.1 | 8.4 | 339.0 | 339.3 | 158.8 |
| Total Liabilities | 17.5 | 16.8 | 19.1 | 17.6 | 15.6 | 17.9 | 349.5 | 345.8 | 166.8 |
| Stockholders' Equity | |||||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (313.0) | (283.1) | (256.4) | (235.9) | (215.6) | (197.6) | (181.1) | (165.2) | (119.4) |
| Accumulated Other Comprehensive Income | (0.4) | (0.1) | 0.5 | 0.4 | 0.2 | 0.3 | 0.4 | 0.8 | 0 |
| Total Stockholders' Equity | 265.8 | 288.2 | 306.8 | 321.7 | 336.4 | 351.8 | (163.7) | (148.5) | (114.9) |
| Total Liabilities & Equity | 283.2 | 305.0 | 326.0 | 339.3 | 352.0 | 369.7 | 185.8 | 197.3 | 51.9 |
| Debt Metrics | |||||||||
| Total Debt | 8.1 | 8.4 | 8.7 | 9.0 | 9.2 | 9.5 | 9.7 | 10.0 | 10.5 |
| Net Debt | (55.3) | (54.9) | (49.8) | (41.9) | (31.7) | (73.2) | (28.0) | (25.8) | (28.0) |
| Metric | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Net Income | (56.7) | (26.8) | (20.4) | (20.3) | (18.1) | (16.5) | (15.8) | (25.4) | (8.6) | (11.8) | (11.9) |
| Depreciation & Amortization | 0.3 | 0.2 | 0.5 | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Stock-Based Compensation | 13.4 | 6.6 | 3.8 | 3.3 | 2.8 | 2.1 | 1.1 | 1.0 | 1.0 | 0.6 | 0.6 |
| Change in Working Capital | (1.4) | (2.1) | (0.3) | 1.9 | (2.4) | (1.9) | 3.1 | (1.6) | (2.1) | (2.5) | 3.1 |
| Other Non-Cash Items | 0.3 | 0.3 | (0.2) | (0.3) | (0.7) | (0.2) | (0.3) | 8.1 | (0.6) | 0.4 | 0.6 |
| Operating Cash Flow | (44.1) | (21.8) | (16.6) | (15.2) | (18.2) | (16.3) | (11.8) | (17.7) | (10.1) | (13.2) | (7.5) |
| Investing Activities | |||||||||||
| Capital Expenditure | 0 | 0 | (0.2) | (0.1) | 0 | (0.1) | (0.0) | 0 | 0 | 0 | (0.1) |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (58.4) | (25.3) | (42.9) | (54.1) | (56.4) | (171.6) | (7.2) | (23.1) | (28.6) | (123.9) | 0 |
| Sales/Maturities of Investments | 104.6 | 50.1 | 65.7 | 77.3 | 33.2 | 30.5 | 22.5 | 33.5 | 0 | 0 | 7.2 |
| Other Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | 46.3 | 24.8 | 22.6 | 23.1 | (23.2) | (141.2) | 15.2 | 10.4 | (28.6) | (123.9) | 7.1 |
| Financing Activities | |||||||||||
| Net Debt Issuance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.6) | 0 | 0 | 0 | 0 | 0 | (1.4) | (1.1) | 0 | 0.0 | 0 |
| Financing Cash Flow | 2.6 | 1.9 | 1.7 | 2.0 | (0.3) | 202.4 | (1.4) | (1.0) | 0.0 | 181.3 | 0 |
| Cash Position | |||||||||||
| Net Change in Cash | 4.9 | 4.9 | 7.6 | 9.8 | (41.7) | 44.9 | 2.0 | (8.3) | (38.7) | 44.2 | (0.3) |
| Cash at Beginning | 59.4 | 58.5 | 51.8 | 41.0 | 83.7 | 38.8 | 36.7 | 45.0 | 83.7 | 39.5 | 39.8 |
| Cash at End | 64.3 | 63.3 | 59.4 | 50.8 | 41.9 | 83.7 | 38.8 | 36.7 | 45.0 | 83.7 | 39.5 |
| Free Cash Flow | (44.1) | (21.8) | (16.8) | (15.3) | (18.2) | (16.4) | (11.8) | (17.7) | (10.1) | (13.2) | (7.6) |
| Key Metrics | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 | 2025 Q1 | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | (0.2) | (0.2) | 0 | (0.1) | 0 | 0 | 0 | (0.2) | 0 | 0 |
| Operating Income | (32.5) | (29.6) | (23.6) | (23.8) | (21.9) | (19.7) | (18.1) | (28.0) | (11.3) | (13.1) | (12.6) |
| Net Income | (29.9) | (26.8) | (20.4) | (20.3) | (18.1) | (16.5) | (15.8) | (25.4) | (8.6) | (11.8) | (11.9) |
| EPS (Diluted) | -0.66 | -0.60 | -0.46 | -0.46 | -0.41 | -0.37 | -0.36 | -0.58 | -0.19 | -0.27 | -0.27 |
| Balance Sheet | |||||||||||
| Cash & Equivalents | 63.3 | 63.3 | 58.5 | 50.8 | 41.0 | 82.7 | 37.8 | 35.7 | 38.5 | ||
| Total Assets | 283.2 | 305.0 | 326.0 | 339.3 | 352.0 | 369.7 | 185.8 | 197.3 | 51.9 | ||
| Total Debt | 8.1 | 8.4 | 8.7 | 9.0 | 9.2 | 9.5 | 9.7 | 10.0 | 10.5 | ||
| Stockholders' Equity | 265.8 | 288.2 | 306.8 | 321.7 | 336.4 | 351.8 | (163.7) | (148.5) | (114.9) | ||
| Cash Flow | |||||||||||
| Operating Cash Flow | (44.1) | (21.8) | (16.6) | (15.2) | (18.2) | (16.3) | (11.8) | (17.7) | (10.1) | (13.2) | (7.5) |
| Capital Expenditure | 0 | 0 | (0.2) | (0.1) | 0 | (0.1) | (0.0) | 0 | 0 | 0 | (0.1) |
| Free Cash Flow | (44.1) | (21.8) | (16.8) | (15.3) | (18.2) | (16.4) | (11.8) | (17.7) | (10.1) | (13.2) | (7.6) |